New funding awards - March 2017

Sponsored Research

John H. Alexander of Cardiology has received a sub-award (1U01-HL133817-01) through Rutgers University for a project entitled "Myocardial Ischemia and Transfusion (MINT)." Total funding will be $50,000.

Brian Gilmore (Mentor: Christopher Kontos) of Cardiology has received an award (1F32-HL136125-01) from the National Institutes of Health for a project entitled "The role of muscle progenitor cells in muscle and vascular regeneration in PAD." Total funding will be $190,722.

Michael D. Gunn of Cardiology has received an award (1R21-AI128405-01) from the National Institutes of Health for a project entitled "Generation of Zika virus-specific recombinant antibodies." Total funding will be $437,250.

Sreekanth Vemulapalli of Cardiology has received a sub-award through the Mayo Clinic for a project entitled "Improving Data Completeness and Expanding Available Data Elements in the TVT Registry through the use of Electronic Health Record Based Data: Linking the TVT Registry and PCORnet." Total funding will be $250,000.

Ashley Williams (Mentor: Deborah Muoio) of Endocrinology, Metabolism, and Nutrition has received an award (3F32-DK105922-02S1) from the National Institutes of Health for a project entitled "Mitochondrial Protein Acetylation and Energy Metabolism in Muscle."

L. Ebony Boulware of General Internal Medicine has received a sub-award (3UL1-TR001857-01S1) through the University of Pittsburgh for a project entitled "University of Pittsburgh Clinical and Translational Science Institute (CTSI) ACT Administrative Supplement." Total funding will be $39,750.

L. Ebony Boulware of General Internal Medicine has received a sub-award (1R21-DK112100-01) through the University of California - San Francisco for a project entitled "Tailored Decision Aids for Elderly Patients and Families Approaching End-Stage Renal Disease." Total funding will be $18,320.

Nia Mitchell of General Internal Medicine has received an award (7 K01-HL115599-06) from the National Institutes of Health for a project entitled "Evaluation of Low Cost National Weight Loss Program in Underserved." Total funding will be $170,640.

Daniel W. Belsky of Geriatrics has received an award (1R21-AG054846-01) from the National Institutes of Health for a project entitled "A pilot study to advance translation of molecular signatures of biological aging." Total funding will be $437,250.

Nelson J. Chao of Hematological Malignancies and Cellular Therapy has received an award from the Gateway for Cancer Research for a project entitled "A Controlled Study of Stem Cell Transplantation Medical Home Care Compared to Standard Hospital Care." Total funding will be $455,623.

Deverick J. Anderson of Infectious Diseases has received a sub-award (U54-CK000484) through Harvard Pilgrim Health Care, Inc. for a project entitled "CLUSTER Trial for Outbreak Detection and Response." Total funding will be $212,881.

Arthur W. Baker of Infectious Diseases has received a sub-award through Rush University Medical Center for a project entitled "Chlorhexidine Gluconate Bathing Evaluation and Comparison Project (CHECkuP)." Total funding will be $36,613.

Mehri McKellar of Infectious Diseases has received an award from Wake County Human Services for a project entitled "Ryan White Region 6 Network of Care." Total funding will be $44,166.

Susanna Naggie of Infectious Diseases has received an award (1R01-DK112295-01) from the National Institutes of Health for a project entitled "Identification of Novel Bioactive Lipid Metabolites for Predicting Liver-related Outcomes in Persons Co-Infected with HIV and HCV." Total funding will be $1,961,760.

John Perfect of Infectious Diseases has received a sub-award (1R01-AI123315-01A1) through Rutgers University for a project entitled "The Role of Host Inositol in Cryptococcus Biology and Pathogenesis." Total funding will be $39,750.

Jason E. Stout of Infectious Diseases has received an award from the NC Department of Health and Human Services for a project entitled "Epidemiology/General Communicable Disease Control." Total funding will be $85,933.

Andrew B. Nixon of Medical Oncology has received a sub-award (5U01-AI063594-13) through the Mount Sinai School of Medicine for a project entitled "CTOT - Cell Free DNA." Total funding will be $198,535.

Myles Wolf of Nephrology has received a sub-award (5R01-DK099199-03) through the University of Washington for a project entitled "Vitamin D Catabolism in Chronic Kidney Disease." Total funding will be $25,423.

Michael Merson of Other Medicine has received a sub-award through Johns Hopkins University School of Public Health for a project entitled "Control of Childhood Diarrhea Mortality: Past Success and Future Prospects." Total funding will be $9,936.

Industry-sponsored Clinical Trials

Brett D. Atwater of Cardiology has received an award from the Boston Scientific Corporation for a project entitled "Physical Activity Leading Up to Hospitalization for Heart Failure." Total funding will be $80,634.

Christopher Granger of Cardiology has received an award from Janssen Pharmaceutical, Inc. for a project entitled "Janssen AF Quality Improvement Research Study." Total funding will be $446,000.

William S. Jones of Cardiology has received an award from Bayer HealthCare AG for a project entitled "Panachen 17582." Total funding will be $31,932.

Raymond J. Kim of Cardiology has received an award from Abiomed for a project entitled "Door To Unloading with IMPELLA CP System in Acute Myocardial Infarction to Reduce Infarct Size (DTU): A Prospective Feasibility Study." Total funding will be $261,376.

Manesh R. Patel of Cardiology has received an award from Volcano Corporation for a project entitled "DEFINE-PCI." Total funding will be $256,235.

Sudarshan Rajagopal of Cardiology has received an award from United Therapeutics Corporation for a project entitled "An Open-Label Extension study of Inhaled Treprostinil in Subjects with Pulmonary Hypertension due to Parenchymal Lung Disease." Total funding will be $88,564.

Sudarshan Rajagopal of Cardiology has received an award from United Therapeutics Corporation for a project entitled "A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects with Pulmonary Hypertension due to Parenchymal Lung Disease." Total funding will be $81,880.

Paul S. Jowell of Gastroenterology has received an award from Medtronic, Inc. for a project entitled "Medtronic Advanced Crt Implant Educational Program." Total funding will be $21,965.

Rodger A. Liddle of Gastroenterology has received an award from BenevolentAI for a project entitled "Analysis of the therapeutic effects of BenevolentAI compound BAI5007 on the development of pancreatitis in the caerulein mouse model." Total funding will be $64,991.

Andrew J. Muir of Gastroenterology has received an award from Gilead Sciences, Inc. for a project entitled "Gilead 428-4025 - A Phase 2, Randomized, Double-Blind, Placebo Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects with Primary Sclerosing Cholangitis Without Cirrhosis." Total funding will be $265,255.

Andrew J. Muir of Gastroenterology has received an award from Gilead Sciences, Inc. for a project entitled "A Phase 2, Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed-Dose Combination and Ribavirin for 12 Weeks in Subjects with Chronic HCV Infection and Child-Pugh-Turcotte Class Cirrhosis." Total funding will be $54,835.

Andrew J. Muir of Gastroenterology has received an award from Gilead Sciences, Inc. for a project entitled "Gilead 427-4024, A Phase 2, Randomized, Double-Blind, Placebo Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects with Primary Biliary Cholangitis Without Cirrhosis." Total funding will be $212,929.

Bradley G. Hammill of General Internal Medicine has received an award from Amgen, Inc. for a project entitled "Trends in Outpatient Heart Failure Management over time." Total funding will be $158,985.

Barbara D. Alexander of Infectious Diseases has received an award from Shire Human Genetics Therapies for a project entitled "A Phase 3, multicenter, randomized, open-label, active-controlled study to assess the efficacy and safety of maribavir treatment compared to Investigator-assigned treatment in transplant recipients with cytomegalovirus (CMV) infections." Total funding will be $95,610.

Andrew Armstrong of Medical Oncology has received an award from Genentech, Inc. for a project entitled "A Phase 1B, Open-Label Study of the Safety and Tolerability of Atezolizumab in Combination with Radium-223 Dichloride in Patients with Castrate-Resistant Prostate Cancer." Total funding will be $335,981.

Jeffrey M. Clarke of Medical Oncology has received an award from AbbVie Inc. for a project entitled "A Phase 1 Dose Escalation and Phase 2 Randomized, Open-Label Study of Nivolumab and Veliparib in Combination with Platinum Doublet Chemotherapy in Subjects with Metastatic or Advanced Non-Small Cell Lung Cancer (NSCLC)." Total funding will be $192,860.

Michael R. Harrison of Medical Oncology has received an award from Pfizer, Inc. for a project entitled "Cardiopulmonary Exercise Testing (CPET) in Patients Treated with Schedule 2/1 and 4/2 for Metastic Renal Cell Carcinoma: A Randomized Multi-Site Trial." Total funding will be $398,698.

Herbert I. Hurwitz of Medical Oncology has received an award from Genentech, Inc. for a project entitled "Phase Ib study of Atezolizumab in combination with Bevacizumab in solid tumor patients." Total funding will be $257,090.

Andrew B. Nixon of Medical Oncology has received an award from Genentech, Inc. for a project entitled "Immune signatures in metastatic colorectal cancer." Total funding will be $331,482.

April K. Salama of Medical Oncology has received an award from Dynavax Technologies Corporation for a project entitled "DV3-MEL-01." Total funding will be $318,154.

Share